Elevate your trading decisions with insights that matter.

The best trades require research, so our Integrated Generative AI solution will do the heavy lifting for you. Our platform allows you to use AI to help you analyze news, earnings calls, and financial data more efficiently.

Gainers
SymbolPriceChange (%)
FEAM
$6.211,971.38%
OTLY
$9.91,767.57%
JTAI
$6.03133.72%
SRM
$0.795.53%
WRD
$31.583.46%
Losers
SymbolPriceChange (%)
HODL
$27.55-74.71%
XHLD
$2.1-69.12%
BLAC
$3.01-55.27%
CSAI
$19.05-49.44%
BSLK
$0.66-46.33%
Actives
SymbolPriceChange (%)
CNSP
$0.1429.87%
MGOL
$0.72-15.08%
SRM
$0.795.53%
INTC
$23.6-2.2%
NVDA
$138.852.63%
Latest Stories
  • seekingalpha.com
    seekingalpha.com icon

    Rezolute is a microcap biopharma focused on developing therapies for hypoglycemia caused by hyperinsulinism, with promising late-stage trials for RZ358 and RZ402. RZ358 targets Congenital Hyperinsulinism and Tumor Hyperinsulinism, showing significant efficacy in reducing hypoglycemia in phase 2 trials. Financially, RZLT has a market cap of $279mn, $105mn in cash, and a cash runway of 5–7 quarters, with manageable expenses.

  • reuters.com
    reuters.com icon

    French IT consulting group Capgemini on Tuesday reported a 2% decline in its full-year sales in constant currency terms, slightly ahead of market expectations.

  • seekingalpha.com
    seekingalpha.com icon

    Ring Energy operates in the Permian Basin with a high liquids mix and substantial reserve life, trading at a significant discount. Despite production increases, sales growth lagged due to lower NGL and natural gas prices, but new transit capacity could alleviate pricing pressures. Management focuses on debt reduction, aiming to reach a 1.0x leverage target by mid-2026, potentially enabling future acquisitions or production expansion.

  • The Dividend Triangle is a simple yet effective framework for identifying high-quality dividend-paying stocks. The Dividend Triangle focuses on three critical metrics that reflect a company's ability to sustain and grow its dividend over time - revenue growth, EPS growth, and dividend growth. Investing in dividend-paying stocks is about more than just yield.

  • seekingalpha.com
    seekingalpha.com icon

    Microsoft's AI revenue has surpassed $13B annually, driven by Azure AI services and Microsoft 365 Copilot, despite the stock underperforming in the hyperscaler complex. However, its free cash flow declined 29% YoY due to increased capex for AI infrastructure, but I believe it to be temporary with easing supply constraints by the end of FY25 and capex slowing in FY26. Simultaneously, efficient AI models like DeepSeek's R1 should lead to faster enterprise adoption, translating to a higher compute demand and operational leverage, benefiting Microsoft's top and bottom lines.

  • U.S. automaker Tesla said on Tuesday it has started mass production of the revamped version of its Model Y in its Shanghai factory.

  • seekingalpha.com
    seekingalpha.com icon

    Fair Isaac keeps executing its price increase strategy and still has room for further increases in the scores segment. Volume growth in mortgage originations (110% YoY), on top of the increase in prices, should boost its free cash flow in FY2025. The growth rate has decreased in the software segment, but management expects it to accelerate in the coming quarters.

  • NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=130140&wire=1 or contact Joseph E. Levi, Esq.

  • seekingalpha.com
    seekingalpha.com icon

    Meta stock has continued to show good bullish momentum in 2025, despite having delivered a massive bull run in 2024. The key metric to look for is the growth in the price per ad impressions, which increased by 14% YoY in the recent quarter as the company delivers more targeted ads. Meta has been able to rapidly monetize the capex on its AI infrastructure, which is why the stock is rewarded compared to Alphabet and Microsoft.

  • seekingalpha.com
    seekingalpha.com icon

    I am downgrading US Foods Holding to a hold rating due to aggressive 2025 growth assumptions, particularly in independent restaurant case volumes. USFD delivered strong 4Q24 results with revenue up 6.2% y/y and adj EBITDA up 13.7% y/y, driven by strategic initiatives. Concerns arise from weakening demand in the independent restaurant category and the risk of USFD missing its FY25 guidance and consensus estimates.

  • youtube.com
    youtube.com icon

    BHP's first-half profit fell 23% due to China's faltering economy prompting the world's biggest public miner to cut its interim dividend to an eight-year low. But CEO Mike Henry struck a positive tone saying that he's "starting to see green shoots" in China's property sector and that demand for BHP's products remains strong despite global economic and trade uncertainties.

  • seekingalpha.com
    seekingalpha.com icon

    The Trade Desk's stock plummeted 34.4% after missing its guidance for the first time in 33 quarters. Is this a pivotal moment at which the fundamental investment thesis for The Trade Desk is broken or not? Despite the setback, TTD remains a leader in programmatic advertising, with 2024 revenue up 26% and strong customer retention.

  • Complaints about BYD , over its move to offer free smart driving features across most of its line-up have flooded a prominent Chinese auto quality platform, many from customers who said they had overpaid for their cars.

  • seekingalpha.com
    seekingalpha.com icon

    Astria Therapeutics' strong cash position and efficient spending provide a financial runway through mid-2027, reducing dilution risk and supporting pivotal trials for navenibart and STAR-0310. Navenibart, targeting hereditary angioedema, shows promising Phase 1b/2 data with a 90-95% reduction in attack rates, positioning it as a potential best-in-class treatment. STAR-0310, aimed at atopic dermatitis, leverages OX40 inhibition and YTE half-life extension technology, though it faces stiff competition and must prove differentiation.

  • NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=130136&wire=1 or contact Joseph E. Levi, Esq.

  • NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=130137&wire=1 or contact Joseph E. Levi, Esq.

  • NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Capri Holdings Limited (NYSE:CPRI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capri-holdings-lawsuit-submission-form?prid=130139&wire=1 or contact Joseph E. Levi, Esq.

  • NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=130138&wire=1 or contact Joseph E.

  • Wise plc leverages competitive pricing and high liquidity to drive demand and sustain growth, especially in cross-border money transfers. The company has shown consistent revenue growth, with Q325 revenue up 13% YoY and nine-month cumulative revenue reaching £1.0B. Increasing market penetration, particularly in Southeast Asia, and the freelancing boom present significant growth opportunities for Wise.

  • HSBC , has laid off around 40 investment bankers in Hong Kong as part of the bank's global restructuring, according to one source with direct knowledge of the matter.

  • seekingalpha.com
    seekingalpha.com icon

    YETI Holdings, Inc. is a premium outdoor brand with effective growth strategies in product enrichment and international expansion, warranting a "BUY" rating with a $52 target price. Key growth drivers include expanding product lines and international revenue growth, which is outpacing US revenue and expected to reach 40-50% of total revenue. Strong recent results with 9% revenue growth, 59% gross margin, and robust cash management.

  • NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=130135&wire=1 or contact Joseph E.

  • NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=130132&wire=1 or contact Joseph E. Levi, Esq.

  • NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=130133&wire=1 or contact Joseph E. Levi, Esq.